VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce its agreement with Ascensia Diabetes Care, a global diabetes care company, to integrate their blood glucose monitoring (BGM) systems, marketed as CONTOUR®NEXT GEN and CONTOUR®NEXT ONE, with Avricore’s pharmacy-based point-of-care testing (POCT) platform, HealthTab. Ascensia Diabetes Care is a subsidiary of PHC Holdings Corporatio
SENSIA Solutions are a highly specialised company dedicated to the design, development and implementation of globally renowned infrared imaging technologies for use in environmental and industrial monitoring applications. Click to read more.
/PRNewswire/ Fast Company Magazine named Censia to this year s list of most innovative companies in Data Science for its AI and machine learning-driven.